The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Atazanavir-Global Market Insights and Sales Trends 2025
Synopsis
Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.
The global Atazanavir market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Atazanavir in various end use industries. The expanding demands from the Adults and Children 3 months of age and older, are propelling Atazanavir market. 150 mg Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 200 mg Capsule segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Atazanavir market, driven by demand from China, the second largest economy with some signs of stabilising, the Atazanavir market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atazanavir, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atazanavir market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atazanavir market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atazanavir sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atazanavir covered in this report include Bristol-Myers Squibb, TEVA, Cipla, Mylan, Aurobindo Pharma and Emcure, etc.
The global Atazanavir market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
TEVA
Cipla
Mylan
Aurobindo Pharma
Emcure
Global Atazanavir market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atazanavir market, Segment by Type:
150 mg Capsule
200 mg Capsule
300 mg Capsule
50 mg Oral Powder
Global Atazanavir market, by Application
Adults
Children 3 months of age and older
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atazanavir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atazanavir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.
The global Atazanavir market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Atazanavir in various end use industries. The expanding demands from the Adults and Children 3 months of age and older, are propelling Atazanavir market. 150 mg Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 200 mg Capsule segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Atazanavir market, driven by demand from China, the second largest economy with some signs of stabilising, the Atazanavir market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atazanavir, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atazanavir market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atazanavir market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atazanavir sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atazanavir covered in this report include Bristol-Myers Squibb, TEVA, Cipla, Mylan, Aurobindo Pharma and Emcure, etc.
The global Atazanavir market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
TEVA
Cipla
Mylan
Aurobindo Pharma
Emcure
Global Atazanavir market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atazanavir market, Segment by Type:
150 mg Capsule
200 mg Capsule
300 mg Capsule
50 mg Oral Powder
Global Atazanavir market, by Application
Adults
Children 3 months of age and older
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atazanavir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atazanavir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Atazanavir Market Overview
1.1 Atazanavir Product Overview
1.2 Atazanavir Market Segment by Type
1.2.1 150 mg Capsule
1.2.2 200 mg Capsule
1.2.3 300 mg Capsule
1.2.4 50 mg Oral Powder
1.3 Global Atazanavir Market Size by Type
1.3.1 Global Atazanavir Market Size Overview by Type (2018-2029)
1.3.2 Global Atazanavir Historic Market Size Review by Type (2018-2023)
1.3.3 Global Atazanavir Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Atazanavir Sales Breakdown by Type (2018-2023)
1.4.2 Europe Atazanavir Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Atazanavir Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Atazanavir Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Atazanavir Sales Breakdown by Type (2018-2023)
2 Global Atazanavir Market Competition by Company
2.1 Global Top Players by Atazanavir Sales (2018-2023)
2.2 Global Top Players by Atazanavir Revenue (2018-2023)
2.3 Global Top Players by Atazanavir Price (2018-2023)
2.4 Global Top Manufacturers Atazanavir Manufacturing Base Distribution, Sales Area, Product Type
2.5 Atazanavir Market Competitive Situation and Trends
2.5.1 Atazanavir Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Atazanavir Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atazanavir as of 2022)
2.7 Date of Key Manufacturers Enter into Atazanavir Market
2.8 Key Manufacturers Atazanavir Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Atazanavir Status and Outlook by Region
3.1 Global Atazanavir Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Atazanavir Historic Market Size by Region
3.2.1 Global Atazanavir Sales in Volume by Region (2018-2023)
3.2.2 Global Atazanavir Sales in Value by Region (2018-2023)
3.2.3 Global Atazanavir Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Atazanavir Forecasted Market Size by Region
3.3.1 Global Atazanavir Sales in Volume by Region (2024-2029)
3.3.2 Global Atazanavir Sales in Value by Region (2024-2029)
3.3.3 Global Atazanavir Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Atazanavir by Application
4.1 Atazanavir Market Segment by Application
4.1.1 Adults
4.1.2 Children 3 months of age and older
4.2 Global Atazanavir Market Size by Application
4.2.1 Global Atazanavir Market Size Overview by Application (2018-2029)
4.2.2 Global Atazanavir Historic Market Size Review by Application (2018-2023)
4.2.3 Global Atazanavir Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Atazanavir Sales Breakdown by Application (2018-2023)
4.3.2 Europe Atazanavir Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Atazanavir Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Atazanavir Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Atazanavir Sales Breakdown by Application (2018-2023)
5 North America Atazanavir by Country
5.1 North America Atazanavir Historic Market Size by Country
5.1.1 North America Atazanavir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Atazanavir Sales in Volume by Country (2018-2023)
5.1.3 North America Atazanavir Sales in Value by Country (2018-2023)
5.2 North America Atazanavir Forecasted Market Size by Country
5.2.1 North America Atazanavir Sales in Volume by Country (2024-2029)
5.2.2 North America Atazanavir Sales in Value by Country (2024-2029)
6 Europe Atazanavir by Country
6.1 Europe Atazanavir Historic Market Size by Country
6.1.1 Europe Atazanavir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Atazanavir Sales in Volume by Country (2018-2023)
6.1.3 Europe Atazanavir Sales in Value by Country (2018-2023)
6.2 Europe Atazanavir Forecasted Market Size by Country
6.2.1 Europe Atazanavir Sales in Volume by Country (2024-2029)
6.2.2 Europe Atazanavir Sales in Value by Country (2024-2029)
7 Asia-Pacific Atazanavir by Region
7.1 Asia-Pacific Atazanavir Historic Market Size by Region
7.1.1 Asia-Pacific Atazanavir Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Atazanavir Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Atazanavir Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Atazanavir Forecasted Market Size by Region
7.2.1 Asia-Pacific Atazanavir Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Atazanavir Sales in Value by Region (2024-2029)
8 Latin America Atazanavir by Country
8.1 Latin America Atazanavir Historic Market Size by Country
8.1.1 Latin America Atazanavir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Atazanavir Sales in Volume by Country (2018-2023)
8.1.3 Latin America Atazanavir Sales in Value by Country (2018-2023)
8.2 Latin America Atazanavir Forecasted Market Size by Country
8.2.1 Latin America Atazanavir Sales in Volume by Country (2024-2029)
8.2.2 Latin America Atazanavir Sales in Value by Country (2024-2029)
9 Middle East and Africa Atazanavir by Country
9.1 Middle East and Africa Atazanavir Historic Market Size by Country
9.1.1 Middle East and Africa Atazanavir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Atazanavir Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Atazanavir Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Atazanavir Forecasted Market Size by Country
9.2.1 Middle East and Africa Atazanavir Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Atazanavir Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Atazanavir Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Atazanavir Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 TEVA
10.2.1 TEVA Company Information
10.2.2 TEVA Introduction and Business Overview
10.2.3 TEVA Atazanavir Sales, Revenue and Gross Margin (2018-2023)
10.2.4 TEVA Atazanavir Products Offered
10.2.5 TEVA Recent Development
10.3 Cipla
10.3.1 Cipla Company Information
10.3.2 Cipla Introduction and Business Overview
10.3.3 Cipla Atazanavir Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cipla Atazanavir Products Offered
10.3.5 Cipla Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Atazanavir Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Atazanavir Products Offered
10.4.5 Mylan Recent Development
10.5 Aurobindo Pharma
10.5.1 Aurobindo Pharma Company Information
10.5.2 Aurobindo Pharma Introduction and Business Overview
10.5.3 Aurobindo Pharma Atazanavir Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Aurobindo Pharma Atazanavir Products Offered
10.5.5 Aurobindo Pharma Recent Development
10.6 Emcure
10.6.1 Emcure Company Information
10.6.2 Emcure Introduction and Business Overview
10.6.3 Emcure Atazanavir Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Emcure Atazanavir Products Offered
10.6.5 Emcure Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Atazanavir Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Atazanavir Industrial Chain Analysis
11.4 Atazanavir Market Dynamics
11.4.1 Atazanavir Industry Trends
11.4.2 Atazanavir Market Drivers
11.4.3 Atazanavir Market Challenges
11.4.4 Atazanavir Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Atazanavir Distributors
12.3 Atazanavir Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
